Literature DB >> 33385409

15-Hydroxy-8(17),13(E)-labdadiene-19-carboxylic acid (HLCA) inhibits proliferation and induces cell cycle arrest and apoptosis in ovarian cancer cells.

Hadi Bakhtiari1, Ali Gheysarzadeh1, Mustafa Ghanadian2, Mahmoud Aghaei3.   

Abstract

AIM: 15-Hydroxy-8(17),13(E)-labdadiene-19-carboxylic acid (HLCA) isolated from Juniperus foetidissima, has been recently identified as an antiproliferative agent; however, the molecular basis of antiproliferative effects of HLCA remains unknown. To investigate it, the current study has emphasized the hypothesis that HLCA induced cell death is a consequence of intracellular reactive oxygen species (ROS) production followed by cell cycle arrest and apoptosis. MAIN
METHODS: Human ovarian OVCAR-3 and Caov-4 cells were treated with various concentrations of HLCA (48 h) and the measurement of intracellular ROS was considered. Then, the potential of HLCA in promoting apoptosis was investigated via flow cytometry, western blot, and caspase activity assay. Also, the inhibitory effect of HLCA on the cell cycle was evaluated using flow cytometry and western blot analysis. KEY
FINDINGS: We found intracellular (ROS) accumulation in HLCA-treated cells. Subsequent observation of the increment in pro-apoptotic Bax as well as the decrement in antiapoptotic Bcl2 revealed that the HLCA-induced cytotoxicity may be triggered by the intrinsic pathway of apoptosis. Our subsequent experiments suggested that caspase-9 and -3 were activated and led the cells to apoptosis during the process. Cell cycle disruption at the G1 phase via down-regulation of cyclin D1 and Cyclin-dependent kinase 4 (CDK4) was another proved mechanism by which HLCA exerts its antiproliferative effects on the ovarian cell lines, OVCAR-3 and Caov-4, especially at relatively lower concentrations. SIGNIFICANCE: This is the first study that reveals the apoptotic effects of HLCA, suggesting its therapeutic potential as an effective anti-tumor agent. However, further in vivo studies are required to confirm these effects.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  15-Hydroxy-8(17),13(E)-labdadiene-19-carboxylic acid; Apoptosis; Cell cycle; Juniperus foetidissima; Ovarian cancer cell lines

Year:  2020        PMID: 33385409     DOI: 10.1016/j.lfs.2020.118981

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  2 in total

1.  Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods.

Authors:  Zi-Qian Liang; Rong-Quan He; Jia-Yuan Luo; Zhi-Guang Huang; Jie Li; Lu-Yang Zhong; Jun-Hong Chen; Su-Ning Huang; Lin Shi; Kang-Lai Wei; Jiang-Hui Zeng; Jing-Jing Zeng; Gang Chen
Journal:  Pathol Oncol Res       Date:  2022-07-15       Impact factor: 2.874

2.  Exosome Component 4 Promotes Epithelial Ovarian Cancer Cell Proliferation, Migration, and Invasion via the Wnt Pathway.

Authors:  Chang Xiong; Zhongfeng Sun; Jinjin Yu; Yaying Lin
Journal:  Front Oncol       Date:  2021-12-08       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.